MEDIRAD formulation of science-based recommendations for medical radiation protection: a stakeholder forum survey

被引:7
|
作者
Benderitter, M. [1 ]
Reyes, E. Herrera [1 ]
Benadjaoud, M. A. [1 ]
Vanhavere, F. [2 ]
Impens, N. [2 ]
Mayerhofer-Sebera, U. [3 ]
Hierath, M. [3 ]
Jourdain, J. R. [1 ]
Frija, G. [4 ]
Repussard, J. [5 ]
机构
[1] Inst Radioprotect & Surete Nucl IRSN, 31 Ave Div Leclerc,BP17, F-92262 Fontenay Aux Roses, France
[2] Belgian Nucl Res Ctr SCK CEN, Boeretang 200, B-2400 Mol, Belgium
[3] European Inst Biomed Imaging Res EIBIR, Gestade 1, A-1010 Vienna, Austria
[4] Univ Paris UP, 85 Bd St Germain, F-75006 Paris, France
[5] Jacques Repussard Conseil, 7 Allee Foret Marly, F-78860 St Nom La Breteche, France
基金
欧盟地平线“2020”;
关键词
medical radiation protection; stakeholder; questionnaire; recommendation; MEDIRAD; RADIOTHERAPY; CANCER;
D O I
10.1051/radiopro/2021030
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
MEDIRAD (Implications of Medical Low Dose Radiation Exposure) is an innovative European research project funded by EURATOM which seeks to bring closer together the nuclear and medical research communities in order to advance science for radiation protection in radiotherapy, nuclear medicine, and diagnostic and interventional radiology. The project also aims to promote links between science and society, with the goal of better protecting patients and professionals, through the publication of recommendations based on MEDIRAD research findings (http://www.medirad-project.eu/). The MEDIRAD Stakeholder Forum (SF) was designed to set up a dialogue between the Consortium member organisations and the society regarding the recommendations, which are expected from this project. We envisage three successive steps in this dialogue (1: first SF consultation identifying the needs for improved medical radiological protection; 2: drafting science based MEDIRAD recommendation and 3: second SF consultation to collect feedback), which are implemented throughout the project. A first overview of input of the Stakeholder Forum about the topics to be addressed in the MEDIRAD recommendations, based on an exploratory questionnaire, is presented in this article. Quantitative and qualitative in-depth analysis leads to the identification of 11 priority thematics.
引用
收藏
页码:275 / 285
页数:11
相关论文
共 50 条
  • [1] Science-based stakeholder dialogues: Theories and tools
    Welp, Martin
    de la Vega-Leinert, Anne
    Stoll-Kleemann, Susanne
    Jaeger, Carlo C.
    GLOBAL ENVIRONMENTAL CHANGE-HUMAN AND POLICY DIMENSIONS, 2006, 16 (02): : 170 - 181
  • [2] Science-based Stakeholder Dialogue for Environmental Policy Implementation
    Brites, Alice Dantas
    de Mello, Kaline
    Tavares, Paulo Andre
    Metzger, Jean Paul
    Rodrigues, Ricardo Riberio
    Molin, Paulo Guilherme
    Guedes Pinto, Luis Fernando
    Joly, Carlos Alfredo
    Adrien Fernandes, Joao Franciso
    Machado, Frederico Soares
    Trani, Eduardo
    Sparovek, Gerd
    CONSERVATION & SOCIETY, 2021, 19 (04): : 225 - 235
  • [3] Science-Based Neurorehabilitation: Recommendations for Neurorehabilitation From Basic Science
    Nielsen, Jens Bo
    Willerslev-Olsen, Maria
    Christiansen, Lasse
    Lundbye-Jensen, Jesper
    Lorentzen, Jakob
    JOURNAL OF MOTOR BEHAVIOR, 2015, 47 (01) : 7 - 17
  • [4] Stakeholder involvement in developing environmental radiation, protection policy and recommendations
    Till, J
    RADIOLOGICAL PROTECTION OF THE ENVIRONMENT: THE PATH FORWARD TO A NEW POLICY?, 2002, : 217 - 226
  • [5] Communicating science-based recommendations with memorable and actionable guidelines
    Ratner, Rebecca K.
    Riis, Jason
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 : 13634 - 13641
  • [6] Clinical research and science-based medical education
    Lehnert, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (22) : 1161 - 1161
  • [7] Linear, no threshold model in radiation protection and safety: standards thrive on 'assumptions' and not on science-based evidence
    Kesavan, P. C.
    CURRENT SCIENCE, 2017, 112 (12): : 2349 - 2350
  • [8] The Journal of Pharmaceutical Innovation: a Forum for Discussion of Science-Based Strategy and Regulatory Requirements
    Drennen, James K., III
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2012, 7 (01) : 1 - 1
  • [9] The Journal of Pharmaceutical Innovation: a Forum for Discussion of Science-Based Strategy and Regulatory Requirements
    James K. Drennen
    Journal of Pharmaceutical Innovation, 2012, 7 : 1 - 1
  • [10] Science-based Policy Recommendations for Fine Particulate Matter in the United States
    Cromar, Kevin R.
    Lee, Alison G.
    Harkema, Jack R.
    Annesi-Maesano, Isabella
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (09) : 1067 - 1069